DK671188D0 - Acylderivater af 5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater til behandling af pulmonaere, astmatiske, allergiske eller inflammatoriske tilstande - Google Patents

Acylderivater af 5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater til behandling af pulmonaere, astmatiske, allergiske eller inflammatoriske tilstande

Info

Publication number
DK671188D0
DK671188D0 DK671188A DK671188A DK671188D0 DK 671188 D0 DK671188 D0 DK 671188D0 DK 671188 A DK671188 A DK 671188A DK 671188 A DK671188 A DK 671188A DK 671188 D0 DK671188 D0 DK 671188D0
Authority
DK
Denmark
Prior art keywords
treatment
allergic
pulmonary
astmatic
acyl derivatives
Prior art date
Application number
DK671188A
Other languages
English (en)
Other versions
DK671188A (da
Inventor
Frederick Judson Walker
John Lawrence Lamattina
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK671188D0 publication Critical patent/DK671188D0/da
Publication of DK671188A publication Critical patent/DK671188A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Liquid Carbonaceous Fuels (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
DK671188A 1987-12-02 1988-12-01 Acylderivater af 5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater til behandling af pulmonaere, astmatiske, allergiske eller inflammatoriske tilstande DK671188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/003171 WO1989005295A1 (en) 1987-12-02 1987-12-02 Acyl derivatives of hydroxypyrimidines

Publications (2)

Publication Number Publication Date
DK671188D0 true DK671188D0 (da) 1988-12-01
DK671188A DK671188A (da) 1989-07-28

Family

ID=22202696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK671188A DK671188A (da) 1987-12-02 1988-12-01 Acylderivater af 5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater til behandling af pulmonaere, astmatiske, allergiske eller inflammatoriske tilstande

Country Status (26)

Country Link
EP (1) EP0319170B1 (da)
JP (1) JPH0725740B2 (da)
KR (1) KR910000415B1 (da)
CN (1) CN1033379A (da)
AT (1) ATE86983T1 (da)
AU (1) AU609547B2 (da)
CA (1) CA1336516C (da)
DD (1) DD277275A5 (da)
DE (1) DE3879410T2 (da)
DK (1) DK671188A (da)
EG (1) EG19003A (da)
ES (1) ES2053769T3 (da)
FI (1) FI893648A7 (da)
HU (1) HU206203B (da)
IE (1) IE63456B1 (da)
IL (1) IL88512A0 (da)
MX (1) MX14001A (da)
MY (1) MY103499A (da)
NO (1) NO893105L (da)
NZ (1) NZ227163A (da)
PL (1) PL158165B1 (da)
PT (1) PT89124B (da)
RU (1) RU2036909C1 (da)
WO (1) WO1989005295A1 (da)
YU (1) YU47013B (da)
ZA (1) ZA888969B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE133545T1 (de) * 1988-12-21 1996-02-15 Massachusetts Inst Technology Verfahren für laserinduzierte fluoreszenz von gewebe
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
KR20170057191A (ko) * 2017-05-04 2017-05-24 김점식 유압을 이용한 전기 자동차 구동장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) * 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines

Also Published As

Publication number Publication date
EP0319170B1 (en) 1993-03-17
HU894552D0 (en) 1990-11-28
YU47013B (sh) 1994-11-15
EP0319170A3 (en) 1990-08-01
NO893105L (no) 1989-09-27
MX14001A (es) 1993-06-01
FI893648A0 (fi) 1989-08-01
DE3879410D1 (de) 1993-04-22
NZ227163A (en) 1990-11-27
RU2036909C1 (ru) 1995-06-09
YU217988A (en) 1990-10-31
PL276122A1 (en) 1989-06-12
EP0319170A2 (en) 1989-06-07
PT89124B (pt) 1993-04-30
IL88512A0 (en) 1989-06-30
KR910000415B1 (ko) 1991-01-25
CN1033379A (zh) 1989-06-14
ATE86983T1 (de) 1993-04-15
MY103499A (en) 1993-06-30
NO893105D0 (no) 1989-08-01
WO1989005295A1 (en) 1989-06-15
DD277275A5 (de) 1990-03-28
JPH0725740B2 (ja) 1995-03-22
JPH01250364A (ja) 1989-10-05
AU609547B2 (en) 1991-05-02
ES2053769T3 (es) 1994-08-01
FI893648A7 (fi) 1989-08-01
CA1336516C (en) 1995-08-01
IE63456B1 (en) 1995-04-19
AU2647088A (en) 1989-06-08
PT89124A (pt) 1988-12-01
ZA888969B (en) 1990-07-25
DK671188A (da) 1989-07-28
HU206203B (en) 1992-09-28
IE883598L (en) 1989-06-02
DE3879410T2 (de) 1993-06-24
HUT55003A (en) 1991-04-29
EG19003A (en) 1994-06-30
PL158165B1 (pl) 1992-08-31
KR890009890A (ko) 1989-08-04

Similar Documents

Publication Publication Date Title
ES2000734A6 (es) Un procedimiento para la preparacion de pirimidinas
DK0534396T3 (da) 2-Substituerede indan-2-carboxyalkylderivater med hæmmende virkning på enkefalinase og ACE
DK0534363T3 (da) 2-substituerede indan-2-mercaptoacetylamid-forbindelse med inhiberende virkning på enkephalinase og ACE.
DK162770C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-heteroaromatiske carboxylater
DK383688D0 (da) 3-desmethyl-mevalonsyrederivater, deres fremstilling og anvendelse samt mellemprodukter ved fremstilling
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
IT8619344A0 (it) Procedimento di purificazione di proteine del latte e di suoi derivati.
NO904921L (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
ATE47999T1 (de) 2-amino-5-hydroxy-4-methylpyrimidin-derivate.
NO950784L (no) Fettsyrederivater
NO914217D0 (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
DK0434057T3 (da) Indocarbazol-derivater, fremgangsmåder til deres fremstilling og deres anvendelse
DK254386A (da) Pyridinderivater, fremgangsmaade til fremstilling heraf og praeparaterindeholdende disse forbindelser
DK671188A (da) Acylderivater af 5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater til behandling af pulmonaere, astmatiske, allergiske eller inflammatoriske tilstande
DK23289D0 (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK162439C (da) Imidazol-2-ylthioalkansyrer og derivater deraf, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK631989A (da) Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
NO904805D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater.
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
DK258281A (da) 4-(3-jodpropargyloxy) pyrimidinderivater og fremgangsmaade til deres fremstilling
IT7950846A0 (it) Procedimento per la purificazione di triptofano e/o suoi derivati
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä
DK382183D0 (da) I 6-stilling usubstituerede 7-oxo-4-oxa-diazabicyclo(3.2.0)hept-2-en-derivater, fremgangsmader til deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af beta-lactamantibiotika
NO880271D0 (no) Fremgangsmaate for fremstilling av poly-umettede n-3 fettsyrer og deres derivater.

Legal Events

Date Code Title Description
ARF Application refused